Copyright
©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 105255
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.105255
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.105255
Figure 1 The interactions between non-alcoholic fatty liver disease and drug use, focusing on three main pathways: Changes in cytochrome P450 enzymes, oxidative stress, and immunological responses.
NAFLD: Non-alcoholic fatty liver disease; CYPs: Cytochrome P450 enzymes; ROS: Reactive oxygen species, IL-4: Interleukin-4; IgM: Immunoglobulin M; C3: Complement component 3.
- Citation: Salolin Vargas VP, Gasbarra M, Calderon-Martinez E, Shah YR, Dahiya DS, Saenz de Sicilia MG. Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happen. World J Hepatol 2025; 17(3): 105255
- URL: https://www.wjgnet.com/1948-5182/full/v17/i3/105255.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i3.105255